Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells

Blood

Volumn 99, Issue 5, 2002, Pages 1646-1650

  Huang, Yao Qi ^a   Li, Jian Jun ^a   Hu, Liang ^a   Lee, Merlin ^a   Karpatkin, Simon ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; COMPLEMENTARY DNA; DACTINOMYCIN; MESSENGER RNA; THROMBIN;

ANGIOGENESIS; ARTICLE; ENDOTHELIUM CELL; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR BINDING; TUMOR GROWTH; UMBILICAL VEIN;

EID: 0036493752     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.5.1646     Document Type: Article

References (50)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Angiogenesis
3. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
4. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors
5. Regulation of angiogenesis via vascular endothelial growth factor receptors
6. Isolation of angiopoietin-1, a ligand for the TIE-2 receptor, by secretion-trap expression cloning
7. Requisite role of angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis
8. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
9. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis
10. Angiopoietin-1 induces sprouting angiogenesis in vitro
11. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells
12. Thrombin promotes endothelial cell alignment in matrigel in vitro and angiogenesis in vivo
13. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway
14. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors
15. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation
16. Isolation of fibrinogen-fibrin related antigen from human plasma by immune-affinity chromatography: Its characterization in normal subjects and in defibrinating patients with abruptio placentae and disseminated cancer
17. Significance of plasma fibrinopeptide A (FPA) in patients with malignancy
18. Abnormalities of blood coagulation in patients with cancer: Fibrinopeptide A generation and tumor growth
19. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease
20. Thrombin stimulates melanoma tumor cell binding to endothelial cells and subendothelial matrix
21. Presence of the seven transmembrane thrombin receptor on human tumour cells: Effect of activation on tumour adhesion to platelets and tumour tyrosine phosphorylation
22. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis
23. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and metastasis in vivo
24. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo
25. Cellular consequences of thrombin-receptor activation
26. Identification of a family of alternatively spliced mRNA species of angiopoietin-1
27. Signaling pathways involved in thrombin-induced cell protection
28. Thrombin-dependent association of phosphatidylinositol-3 kinase with p60c-src and p59fyn in human platelets
29. p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation
30. Constitutive production and thrombin-induced release of VEGF by human megakaryocytes and platelets
31. In vitro release of VEGF during platelet aggregation
32. Thrombin induces the release of angiopoietin-1 from platelets
33. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
34. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
35. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
36. Cellular localization of enzymatically active thrombin in intact tissue by hirudin binding
37. Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumour growth in vivo
38. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody
39. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinse Tie-2
40. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
41. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas
42. The angiopoietins, Tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas
43. Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines
44. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
45. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
46. Thrombin induces vascular endothelial cell growth factor (VEGF) in human tumor cells and fibroblasts
47. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes
48. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa
49. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF